Cargando…
Metabolite-derived protein modifications modulating oncogenic signaling
Malignant growth is defined by multiple aberrant cellular features, including metabolic rewiring, inactivation of tumor suppressors and the activation of oncogenes. Even though these features have been described as separate hallmarks, many studies have shown an extensive mutual regulatory relationsh...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549695/ https://www.ncbi.nlm.nih.gov/pubmed/36226054 http://dx.doi.org/10.3389/fonc.2022.988626 |
_version_ | 1784805727556075520 |
---|---|
author | Liu, Yawen Vandekeere, Anke Xu, Min Fendt, Sarah-Maria Altea-Manzano, Patricia |
author_facet | Liu, Yawen Vandekeere, Anke Xu, Min Fendt, Sarah-Maria Altea-Manzano, Patricia |
author_sort | Liu, Yawen |
collection | PubMed |
description | Malignant growth is defined by multiple aberrant cellular features, including metabolic rewiring, inactivation of tumor suppressors and the activation of oncogenes. Even though these features have been described as separate hallmarks, many studies have shown an extensive mutual regulatory relationship amongst them. On one hand, the change in expression or activity of tumor suppressors and oncogenes has extensive direct and indirect effects on cellular metabolism, activating metabolic pathways required for malignant growth. On the other hand, the tumor microenvironment and tumor intrinsic metabolic alterations result in changes in intracellular metabolite levels, which directly modulate the protein modification of oncogenes and tumor suppressors at both epigenetic and post-translational levels. In this mini-review, we summarize the crosstalk between tumor suppressors/oncogenes and metabolism-induced protein modifications at both levels and explore the impact of metabolic (micro)environments in shaping these. |
format | Online Article Text |
id | pubmed-9549695 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95496952022-10-11 Metabolite-derived protein modifications modulating oncogenic signaling Liu, Yawen Vandekeere, Anke Xu, Min Fendt, Sarah-Maria Altea-Manzano, Patricia Front Oncol Oncology Malignant growth is defined by multiple aberrant cellular features, including metabolic rewiring, inactivation of tumor suppressors and the activation of oncogenes. Even though these features have been described as separate hallmarks, many studies have shown an extensive mutual regulatory relationship amongst them. On one hand, the change in expression or activity of tumor suppressors and oncogenes has extensive direct and indirect effects on cellular metabolism, activating metabolic pathways required for malignant growth. On the other hand, the tumor microenvironment and tumor intrinsic metabolic alterations result in changes in intracellular metabolite levels, which directly modulate the protein modification of oncogenes and tumor suppressors at both epigenetic and post-translational levels. In this mini-review, we summarize the crosstalk between tumor suppressors/oncogenes and metabolism-induced protein modifications at both levels and explore the impact of metabolic (micro)environments in shaping these. Frontiers Media S.A. 2022-09-23 /pmc/articles/PMC9549695/ /pubmed/36226054 http://dx.doi.org/10.3389/fonc.2022.988626 Text en Copyright © 2022 Liu, Vandekeere, Xu, Fendt and Altea-Manzano https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Liu, Yawen Vandekeere, Anke Xu, Min Fendt, Sarah-Maria Altea-Manzano, Patricia Metabolite-derived protein modifications modulating oncogenic signaling |
title | Metabolite-derived protein modifications modulating oncogenic signaling |
title_full | Metabolite-derived protein modifications modulating oncogenic signaling |
title_fullStr | Metabolite-derived protein modifications modulating oncogenic signaling |
title_full_unstemmed | Metabolite-derived protein modifications modulating oncogenic signaling |
title_short | Metabolite-derived protein modifications modulating oncogenic signaling |
title_sort | metabolite-derived protein modifications modulating oncogenic signaling |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549695/ https://www.ncbi.nlm.nih.gov/pubmed/36226054 http://dx.doi.org/10.3389/fonc.2022.988626 |
work_keys_str_mv | AT liuyawen metabolitederivedproteinmodificationsmodulatingoncogenicsignaling AT vandekeereanke metabolitederivedproteinmodificationsmodulatingoncogenicsignaling AT xumin metabolitederivedproteinmodificationsmodulatingoncogenicsignaling AT fendtsarahmaria metabolitederivedproteinmodificationsmodulatingoncogenicsignaling AT alteamanzanopatricia metabolitederivedproteinmodificationsmodulatingoncogenicsignaling |